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Abstract 
Background: Transition from parent‑delivered to self‑management is a vulnerable time for adolescents and young 
adults (AYA) with allergy and asthma. There is currently no European guideline available for healthcare professionals 
(HCPs) on transition of these patients and local/national protocols are also mostly lacking.
Methods: European HCPs working with AYA with allergy and asthma were invited to complete an online survey 
assessing challenges of working with these patients, current transition practices and access to specific healthcare 
resources.
Results: A total of 1179 responses from 41 European countries were collected. Most HCPs (86%) reported a lack of 
a transition guideline and a lack of a transition process (20% paediatric HCPs, 50% of adult HCPs, 56% HCP seeing all 
ages). Nearly half (48%) acknowledged a lack of an established feedback system between paediatric and adult medi‑
cal services. Many respondents never routinely asked about mental health issues such as self‑harm or depression and 
are not confident in asking about self‑harm (66.6%), sexuality (64%) and depression (43.6%). The majority of HCPs 
(76%) had not received specific training in the care of AYA although 87% agreed that transition was important for AYA 
with allergy and asthma.
Conclusion: Although there was agreement that transition is important for AYA with allergy and asthma, there are 
crucial limitations and variations in the current provision of transition services across Europe. Standardisation of AYA 
management and specific training are required. This should improve management and continuity of care during 
adolescence and into adulthood to achieve the best healthcare outcomes.
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Introduction
Allergy and asthma are amongst the most common 
chronic disorders. Furthermore, the prevalence and 
severity of allergic diseases and asthma continue to 
rise with adolescents and young adults (AYA)—those 
between ages 11 and 25 [1–3]. It has been shown that 
AYA have higher rates of fatal anaphylaxis to foods [4] 
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and asthma deaths compared to younger children [5] 
partly due to risk taking behaviour and poor adherence. 
Moreover, AYA with food allergy (FA) have a lower qual-
ity of life (QoL) than AYA with other chronic conditions 
[6]. These findings suggest that AYA with allergic condi-
tions require specialised resources and healthcare plans 
to address their age- and disease-related needs.
Adolescence and young adulthood is an important 
period of development with significant biological, psy-
chological and social changes [7]. As adolescents move 
towards adulthood, there is a need to evolve from being 
dependent on their parents/carers to becoming respon-
sible and accountable for their own health and well-being 
as adults. This is independent of whether there are sepa-
rate paediatric and adult allergy clinics or one allergy 
clinic seeing all age groups. Transition has been defined 
as ‘active and evolving process that addresses the medi-
cal, psychosocial, and educational needs of young peo-
ple as they prepare to move from child- to adult-centred 
health care’ [8]. So it is not only about transfer of patient 
information and disease history to an adult healthcare 
setting. Transition also, importantly, includes the provi-
sion of the support that AYA with long-term allergic con-
ditions require to meet their needs to progress to being 
independent adult patients.
Previous studies have shown that AYA and their par-
ents are mostly dissatisfied with their experience of the 
transition process. For instance, only 42% of AYA with 
special healthcare needs had discussed transition care 
with their healthcare professional (HCP) and only 41% 
met the transition core outcomes such as whether HCP 
had discussed transition to adult medical service, health 
care needs, health insurance and had encouraged the 
AYA to self-manage their disease [9]. AYA with sickle 
cell disease have voiced concern about the care they will 
receive in adult healthcare services, being worried about 
leaving a familiar and trusted paediatric doctor [10]. A 
recent systematic review on the challenges faced by AYA 
with allergy and asthma identified a large number of fixed 
and modifiable factors, including psychological, social/
environmental, behavioural factors as well as the nature 
of the patient-HCP relationship, that will influence self-
management and ultimately health outcomes [11]. In 
addition, a related systematic review assessed different 
interventions for improving self-management and well-
being of AYA with asthma and allergies; many delivered 
improvements in patients with asthma although more 
robust evidence is required, especially for other allergic 
diseases [12]. Given this complexity we need to find ways 
for HCPs to facilitate the smooth transition process from 
a paediatric to adult format of medical care and inform 
transition guidelines.
During the last decade, a number of transition models 
and guidelines have been proposed to address the organi-
zation and process of transition. There are no conclusive 
data on the superiority of one transition programme over 
another [13]. The need for a multidisciplinary service 
model integrating social support, education and non-
statutory services is well established [14] and exemplified 
by the recently published European Academy of Paedi-
atrics consensus statement [15]. Furthermore, a num-
ber of disease-specific programmes have been set up to 
address the process of the transition such as in patients 
with chronic digestive [16], rheumatic [17, 18], liver [8] 
and coeliac [19] diseases.
To our knowledge, there are currently no standard-
ized policies and protocols on the transition of AYA 
with allergy and asthma in most European countries. 
Moreover, there are currently no international or Euro-
pean accepted guidelines available for HCPs working in 
this field. To develop best transition practices for AYA 
with allergic diseases across Europe, it is first necessary 
to understand current transition care, as well as the bar-
riers and facilitators HCPs face to implement quality of 
care. This paper describes the results of a pan-European 
survey to assess the challenges of working with AYA, cur-
rent transition practices and access to specific healthcare 
resources to support transition.
Methods
Study design
A quantitative, online, cross-sectional survey was con-
ducted. As no relevant validated questionnaire existed, 
the survey was developed by the members of the Euro-
pean Academy of Allergy and Clinical Immunology 
(EAACI) Adolescent and Young Adult Task Force after 
a systematic literature review on the transition process 
and challenges of the AYA with allergies. The study was 
approved by the Ethics and Research Governance Com-
mittee at University of Southampton, United Kingdom.
Participants
We invited HCPs managing AYA with allergy and 
asthma across Europe and members of the EAACI and/
or National Allergy Societies (NAS) within Europe who 
were able to read English, German, French, Greek, Span-
ish, Portuguese, Italian or Russian to participate in the 
survey. The potential survey population was approxi-
mately 12,000 participants, the number of EAACI mem-
bers, in addition to members of the NAS. As it was not 
possible to identify non-clinicians, the survey was sent 
to all EAACI members and it was highlighted in the invi-
tation email that the survey was only for HCPs. Partici-
pants were asked to fill in the survey only once. A margin 
of error for answers to questions was set at 5% with a 
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confidence level of 95%. For this, the SurveyMonkey tool 
(https ://www.surve ymonk ey.com/mp/sampl e-size-calcu 
lator /) indicated that a sample size of 373 participants 
was required to provide good estimates given the overall 
population size of 12,000.
Data collection
The survey was distributed by the scientific content 
officer of EAACI and presidents of NAS in Europe via a 
link to the survey in SurveyMonkey through the mem-
bers’ mailing list. In addition, the survey was advertised 
on social media (e.g. Facebook, Twitter) and during the 
EAACI 2019 congress. Before accessing the question-
naire, potential respondents were informed about the 
study’s purpose, average time required to complete the 
survey and confidentiality policy on the last page of the 
SurveyMonkey. The survey was conducted between 30th 
May and 28th June 2019. Two reminder emails were sent.
The questionnaire
The anonymized survey consisted of 25 questions (see 
supplementary materials). The questionnaire was trans-
lated into eight languages (English, German, French, 
Greek, Spanish, Portuguese, Italian and Russian) and 
back-translated into English to ensure validity. To reduce 
measurement error, some words, which could have sev-
eral meanings or did not have a direct translation such 
as transition, transition lead, transition readiness assess-
ment tool and transition report were described in the 
glossary at the beginning of the survey. A pilot on-line 
survey was conducted with 20 volunteer HCPs from the 
target group in different countries who were not mem-
bers of the EAACI Task Force to optimize clarity, rel-
evance and web administration. They also tested the time 
required to complete the survey, which ranged from 8 to 
11 min.
To enhance completion rates for the survey and to keep 
it brief, minimal demographic and training information 
was collected. An option for other free-text response 
was permitted in each question. Data from the free-text 
answers was coded as ‘other’ and described in the foot-
notes of tables and figures.
Statistical analysis
All data was collected and analyzed using SPSS software 
version 25.0. Descriptive statistics were used to describe 
respondent characteristics. Means, medians, standard 
deviations, and lower and upper quartiles are presented 
for continuous variables. Frequency tables with percent-
ages are provided for categorical variables. Categorical 
variables were compared using Chi square or Fisher’s 
exact test as appropriate. Association between clinic type 
(paediatric, all ages groups HCP), countries with more 
than 50 responses and investigated parameters were 
assessed by multiple regression analysis.
Two sub-analyses were performed, one amongst HCPs 
from different geographic regions and one amongst 
pediatricians, adults, or all ages HCPs. A minimum of 50 
responders per country was required for comparison of 
data between countries to ensure that there was adequate 
power to detect significant differences. Summary tables 
and bar charts were used to represent the results. Data 
was considered significant if statistical tests produce a p 
value of < 0.05.
A qualitative data analysis was used to summarise 
HCP’s comments. Text was divided into separate units, 
coded and summarized as themes. Each response was 
reviewed by EK and GR. Any discrepancies were resolved 
through discussion and, if necessary, a third reviewer 
(MVO) was consulted.
Results
Respondent demographics and characteristics
We received 1819 responses, 550 were incomplete and 
14 were excluded as they did not satisfy the inclusion cri-
teria. A total of 1255 responses from 71 countries were 
analysed. Further analysis focused on the 1179 responses 
which came from Europe. There were 449 (38.1%) paedia-
tricians, 88 (7.5%) adult physicians and 642 (54.5%) HCPs 
who see all age groups. Respondent’s’ characteristics are 
listed in Table  1. Additionally, a sensitivity analysis was 
performed looking at difference between responses in 
different languages. These findings were similar to those 
for the comparison between different countries (Addi-
tional file 1: Tables S1, S2).
Resources
The majority (51%) of HCP’s consultations with AYA 
usually lasted about 20  min or less. Half of respond-
ers reported that patients had direct access to an allergy 
nurse and about 40% to either allergist, pulmonologist, 
dermatologist or gastroenterologist. Availability of social 
workers and psychologists was mostly lacking (18% and 
24% respectively) (Table 2).
Notably, a total of 906 (77%) responders indicated 
that they had no specific resources to organize the care 
for AYA with allergy and asthma differently than ser-
vices to care for other age groups. Specific resources 
such as e-learning materials (7.5%), workshops (7.1%), 
peer support (5.3%), phone hotline (4.7%) or webinars 
(2.8%) were rarely offered (Table  3). The availability of 
specific resources varied significantly between countries 
(p < 0.001 for no available resources, Additional file  1: 
Table S2). The lack of such resources was cited amongst 
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Table 1 Demographics of  survey responders and  practice 
characteristics
European countries (n = 1179) Number (%) 
respondents
Albania 2 (0.2)
Austria 6 (0.5)
Belarus 8 (0.6)
Belgium 7 (0.6)
Bulgaria 4 (0.3)
Croatia 3 (0.2)
Cyprus 1 (0.1)
Czech Republic 26 (2.1)
Denmark 30 (2.4)
Estonia 4 (0.3)
Finland 4 (0.3)
France 46 (3.7)
Germany 68 (5.4)
Greece 34 (2.7)
Hungary 3 (0.2)
Iceland 3 (0.2)
Ireland 31 (2.5)
Italy 110 (8.8)
Kazakhstan 1 (0.1)
Kosovo 2 (0.2)
Latvia 1 (0.1)
Lithuania 6 (0.5)
Moldova 1 (0.1)
Monaco 1 (0.1)
Netherlands 32 (2.5)
Norway 16 (1.3)
Poland 10 (0.8)
Portugal 56 (4.5)
Republic of North Macedonia 8 (0.6)
Romania 54 (4.3)
Russia 175 (13.9)
Serbia 10 (0.8)
Slovakia 19 (1.5)
Slovenia 10 (0.8)
Spain 170 (13.5)
Sweden 29 (2.3)
Switzerland 8 (0.6)
Turkey 35 (2.8)
Ukraine 19 (1.5)
United Kingdom 124 (9.9)
Uzbekistan 2 (0.2)
Non‑European  countriesa 76 (6.1)
Language
 English 537 (45.5)
 Italian 105 (8.9)
 Greek 26 (2.2)
 Spanish 146 (12.4)
 German 74 (6.3)
Table 1 (continued)
European countries (n = 1179) Number (%) 
respondents
 Russian 204 (17.3)
 French 34 (2.9)
EAACI section
 Asthma 292 (24.8)
 Dermatology 57 (4.8)
 ENT 46 (3.9)
 Immunology 99 (8.4)
 Paediatrics 358 (30.4)
 Primary Care and Allied Health 51 (4.3)
 Noneb 276 (23.4)
Profession
 Doctor 1082 (91.8)
 Specialist allergy nurse 68 (5.8)
 Dietician 15 (1.3)
 Othersc 14 (1.2)
Specialitye
 Paediatric allergy 368 (31.2)
 Paediatrics 331 (28.1)
 Allergy (adults only) 138 (11.7)
 Allergy (children and adults) 514 (43.6)
 Dermatology 40 (3.4)
 Respiratory Medicine 172 (14.6)
 Otorhinolaryngology 37 (3.1)
 General practitioner 41 (3.5)
 Internal Medicine 11 (0.9)
 Immunology 16 (1.4)
 Othersd 35 (3.0)
Work  settinge
 Tertiary care 542 (46)
 Secondary care 293 (24.9)
 Primary care 270 (22.9)
 Private practice 283 (24.0)
 Research 7 (0.6)
Years in practice
 0–5 248 (21)
 6–10 261 (22.1)
 11–20 371 (31.5)
 > 21 299 (25.3)
ENT otolaryngology
a Non-European countries (Supplementary materials)
b Member of the National allergy society only
c Psychologist (n = 3, 0.3%), physician assistant allergy (n = 1, 0.1%), nurse 
practitioner in training (n = 2, 0.2%), resident doctor in training (n = 2, 0.2%), 
research associate (n = 3, 0.3%); health visitor (n = 2, 0.2%), medical student 
(n = 1, 0.1%)
d Paediatric respiratory doctor (n = 20; 1.7%); psychologist (n = 3;0.3%); 
tabacology (n = 1;0.1%); sports medicine (n = 2;0.2%); safeguarding (n = 1;0.1%); 
research associate (n = 2; 0.2%); public healthcare (n = 2;0.2%); pharmacology 
(n = 1; 0.1%); infectionist (n = 3; 0.3%)
e Participants were allowed to select more than 1 answer
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Table 2 Consultation
Practice parameters (n = 1179) Number (%) 
respondents
HCPs category based on patient’s  agea
 Paediatric 449 (38.1)
 Adult 88 (7.5)
 All ages groups 642 (54.5)
Time for follow‑up consultation with AYA, minutes
 Up to 10 135 (11.5)
 Up to 20 460 (39.0)
 Up to 30 395 (33.5)
 Up to 45 143 (12.1)
 > 45 46 (3.9)
Direct access to healthcare  professionalsb,c
 Allergy/asthma nurse 597 (50.6)
 Dietician 379 (32.1)
 Paediatric allergist 537 (45.5)
 Adult allergist 437 (37.1)
 Psychologist 293 (24.9)
 Respiratory physiotherapist 279 (23.7)
 Social worker 209 (17.7)
 Gastroenterologist 426 (36.1)
 Pulmonologist 543 (46.1)
 Dermatologists 502 (42.6)
 Otolaryngologist 329 (27.9)
 Referral only 42 (3.6)
 Othersd 4 (0.3)
Is care for AYA in your service organised differently than services to care for other age groups?
 No, specific resources 906 (76.8)
 Yes, for all AYA 207 (17.6)
 Yes, for selected patients  onlye 66 (5.6)
Percentage of AYA transferred to adult services rather than being discharged to GP or no care:
 1–10% 117 (9.9)
 10–25% 123 (10.4)
 25–50% 89 (7.5)
 50–75% 108 (9.2)
 75–100% 99 (8.4)
 Don’t know 167 (14.2)
 No transfer of AYA into adult services 198 (16.8)
 We see all ages 278 (23.6)
Do you know how many of your transfer patients regularly attend the adult clinic after referral:
 No 361 (30.6)
 Yes, please specify the  percentagef 111 (9.4)
 NA, no transfer of patients into adult services 405 (34.4)
 NA, we see all ages 302 (25.6)
Evaluation tools on whether AYA is ready to be sent to adult  serviceb
 No evaluation tool, AYA transferred at a specific age 489 (41.5)
 Patient consent 171 (14.5)
 Parental consent 122 (10.3)
 Checklist of questions/knowledge 50 (4.2)
 Completion of adolescent transition tool 48 (4.1)
 We see all ages 364 (30.9)
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the barriers to a satisfactory transition in comments from 
respondents (Box 1).
Timing of transition
Overall, “My clinic does not have a transition process” 
was chosen by 20% paediatricians, 50% HCPs seeing only 
adults and 56% of those seeing all patients groups (Fig. 1). 
Twenty-eight percent of HCPs indicated that they started 
preparing AYA for transition at about 16–18 years. There 
were significant differences between countries (p < 0.001, 
Additional file  1: Table  S2) in age of start of transition 
process, with significant interactions between clinic type 
and countries (Additional file 1: Figure S1). Almost 40% 
transferred AYA by the 18th year of age (Fig. 1).
Table 2 (continued)
Practice parameters (n = 1179) Number (%) 
respondents
 My clinic does not transfer AYA to adult services 157 (13.3)
Feedback system between paediatric and local adult  serviceb
 No system of feedback in place 569 (48.3)
 The consultation letter from the first visit to adult clinic is sent back to referring paediatrician 150 (12.7)
 Regular meetings to discuss patients 101 (8.6)
 Not applicable, we see all ages 405 (34.4)
AYA adolescent and young adult, GP general practitioner, HCP healthcare professional, NA not applicable
a Paediatric HCP looking after 0–18 years old patients; adult HCP looking after ≥ 18 years old patients
b Participants were allowed to select more than 1 answer
c Direct access- without the referral from HCP
d Other: play therapist, family doctor trained in allergy, health visitor, immunologist
e Data is shown only for 31 (2.8%) responses: adherence problems (n = 1); educational sessions for asthma or peanut allergic patients (n = 1); AYA asthma clinic 
(n = 16); severe or multiple allergies (n = 10); referred to youth service (n = 1); need transition to adult allergy service and not to GP (n = 3); some have more time 
(n = 1); psychiatric problems (n = 2); school problems (n = 1); joint consultation with paediatric and adult allergist (n = 1); deprived backgrounds (n = 1)
f Data is only provided for 58 responses (%): median (LQ,UQ): 62.5 (37.5, 80); minimum 1; maximum 95
Table 3 Resources and  other clinic elements to  support adolescents and  young adults with  allergy and  asthma 
in the medical services across Europe
AYA adolescent and young adult. Participants were allowed to select more than 1 answer
a Others: allergy nurse in the transition clinic; discussion about the transition process, adult clinic and self-management; disease- specific leaflets; referral to support 
groups/psychologist; email hotline; quality of life questionnaire; annual follow up. Results based on data from 1179 respondents
Resources N (%)
No specific resources 906 (76.8)
Consultation without parents present 300 (25.4)
Consultation letters are sent to paediatric or adult colleagues involved in individual patients’ care 289 (24.5)
Communication (emails, texts) addressed directly to the AYA (e.g. medical reports, appointments) 193 (16.4)
Transition report 165 (14.0)
Transition guideline for healthcare professionals 165 (14.0)
Joint transition clinics with the paediatric and adult services 104 (8.8)
Regular meetings involving paediatric and adult services in the field of allergy and pneumology 103 (8.7)
e‑Learning materials 88 (7.5)
Workshops 84 (7.1)
Transition readiness assessment tool 64 (5.4)
Peer learning/peer support for patients 63 (5.3)
Phone hotline 56 (4.7)
Transition lead 48 (4.1)
Transition network 38 (3.2)
Webinars 33 (2.8)
Othersa 12 (1.0)
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Approach to transition
The structure of the transition process varied across 
European countries (e.g. p < 0.001 for no specific 
resources, Additional file  1: Table  S2). One-quarter 
of HCPs reported that they asked AYA whether they 
wanted to have a consultation without parents present, 
while only 16% of total sent medical-related corre-
spondence directly to the AYA (Table 3). Less than 10% 
of HCPs had an established joint transition clinic with 
the paediatric and adult services or regular meetings 
to discuss individual cases. A mere 14% of respondents 
had a transition guideline for their service; 4% had a 
transition lead to oversee and coordinate the transition 
process and only 8.3% reported that they used a transi-
tion assessment tool or checklist of questions to deter-
mine transition readiness.
HCPs said that not all AYA were transfered to a special-
ist adult services. For example, only around half of those 
with poorly controlled asthma or on biological therapy 
were transfered (Additional file  1: Table  S3). Among all 
responses, 30.6%) HCPs did not know whether their AYA 
patients attended the adult clinic after referral. (Table 2). 
Furthermore, nearly half of respondents (48%) reported 
a lack of an established feedback system between pae-
diatric and local adult medical services after the AYA 
transferred care. Only thirteen percent identified that a 
medical report was sent from adult clinic to the referring 
paediatrician and only 9% discussed patients at a regular 
meeting between services (Table 2). There were substan-
tial differences between countries in terms of feedback 
(p < 0.001 for all, Additional file  1: Table  S2). Specific 
comments about approach to transition are summarised 
in Box 1.
Training and challenges for healthcare professionals
A large proportion of HCPs never routinely asked 
about self-harm, sexuality, depression or drug use 
(Fig. 2, Additional file 1: Table S2). There was the same 
pattern of responses regarding confidence in asking and 
giving relevant advice about these areas. For example, 
HCPs were not very confident and not confident in ask-
ing about self-harm (66.6%), sexuality (64%), depression 
(43.6%) and drug use (41.5%). Some respondents com-
mented specifically about importance of open dialogue 
with AYA (Box 1).
Seventy-six percent of all HCPs reported that they had 
not received specific training in the care of AYA (Addi-
tional file 1: Figure S3). Although respondents from clin-
ics for all age groups, compared to paediatric ones, were 
more likely to have specific training (adjusted regres-
sion coefficient 0.033; 95% confidence interval 0.004, 
0.062; p = 0.027), this also varied significantly by country 
(Additional file 1: Figure S3, Table S4). Box 1 summarises 
respondents’ comments concerning training.
Importance of the transition care
Eighty-seven percent reported that they “strongly 
agree” or “agree” with the statement that transition is 
important for AYA with allergies and asthma (Addi-
tional file  1: Figure S5). Of the paediatric HCPs, 64% 
“strongly agree” with the statement while almost 50% 
of adult HCPs and HCPs looking after all ages groups 
chose this answer. The degree to which respondents 
from paediatric clinics (compared to clinics for all age 
groups) were more positive about the importance of 
transition varied by country (Additional file 1: Table S5, 
Figure S6). Notably, only 17% stated that transition is a 
priority in their country (Additional file  1: Figure S5). 
Specific comments from respondents about the impor-
tance of transition care are summarised in Box 1.
Preconceptions and comments about transition process
Some HCPs thought that transition should happen even 
if AYA was not moving between medical services. How-
ever, others commented that they believed that there 
was no need for transition if HCPs cared for all ages of 
patients (Box 1).
Box 1. Example of comments from respondents
A. Adolescent and young adult‑centred transition
Communication
‘An open dialog with the patient and his/her rela-
tives is important as well as involving the patient in the 
treatment decision and plan.’
‘Engage them, tell them what is important, why it is 
important, how to recognise if things are not working. 
Give them control in the process. Understand their cur-
rencies (what is important to them). Let them be part of 
their roadmap.’
‘We should find appropriate communication meth-
ods for the Z generation.’
‘As patients grow up, we involve them more in their 
health issues and we try and find a time to speak to 
them without their parents present.’
‘It’s very important to take into account psychophysi-
ological characteristics of AYA, their behavioural and 
social characteristics in order to make a personalised 
treatment plan.’
‘During this process, consulting a psychologist who is 
specialized in treating adolescents, should be proposed 
easily.’
Page 8 of 15Khaleva et al. Clin Transl Allergy           (2020) 10:40 
B. Barriers for implementation of transition
Lack of time
‘Important but difficult to establish in busy work 
environment without more resources.’
‘I do not have time within my allergy clinic appoint-
ment to offer a full adolescent service.’
Lack of resources
‘Would dearly love to have a robust transition ser-
vice - under-resourced and too many other competing 
priorities.’
‘Plenty of opportunity to improve, but requires 
resources.’
‘The importance of educating young adults about 
their conditions is underestimated however this is 
imperative to help them manage their condition, mini-
mise risk and prevent attacks/anaphylaxis.’
Not enough adult allergy specialists
‘Adult services need funding, otherwise there is 
nowhere to transition the majority to. There is no dieti-
tian in the adult services at my trust.’
‘Most paediatric secondary care allergy services don’t 
have a secondary care service to transition too. There is 
also nowhere to transition young people with multiple 
atopic comorbidities.’
‘We have no adult service for allergy within our hospital.’
‘Not enough adult allergists; not enough time spent 
for discussion with these patients.’
Lack of training
‘Never heard of it before.’
‘This survey has made me realize that I need to learn 
more about the transition process.’
‘Transition process should be known and educated.’
‘Very important if there are dedicated specialists. We 
have none in my country.’
‘Every doctor should have a training on this transi-
tion process.’
‘The problem is to think that allergic patients have to 
be seen by different specialists at different ages but per-
haps we should have additional training to clinically 
evaluate patients of certain ages (children, teens) where 
some specialists may feel less comfortable.’
‘Doctors don’t have specific training in adolescence 
medicine.’
C. Importance of transition
‘Vitally important and should be addressed.’
‘Should be widely available.’
‘Should be implement in all clinic seeing allergy 
patients.’
‘The transition process is very important, we are cur-
rently working on a special transition program in our 
hospital.’
‘Disheartened we don’t have one.’
‘It is probably a luxury! There is so little basic 
allergy service for adults/children in our area that 
I feel they needs to be sorted first. Although I agree 
effective transition is very important abs would 
hugely help.’
‘We are in a process where we plan to do transition 
a high priority.’
‘It is critical that comprehensive and age appro-
priate services are developed for adolescence as this 
is the age group where they are most likely to be at 
risk, particularly if they have life threatening allergy. 
More needs to be done for this age group.’
‘It is very important transition because this cat-
egory of patients is not very compliant…’
‘Transition process should be kept on high level of 
awareness.’
‘It is very important, we should pay higher 
attention.’
D. Transition protocol
‘There should be alignment across practices, health 
systems, countries.’
‘There is a lot of talk about addressing it, but very 
little opportunity for clinicians to get it right.’
‘I will be very happy if our colleges start to think 
about this process and if we change our practice in 
order to create and implement transition protocol.’
‘You highlighted a very important problem. I hope 
that these kind of questionnaires will made other 
doctors think more about this problem, made them 
do more for this particular group of patients so hope-
fully after the survey you will be able make a special 
guideline, algorithm to treat this group of patients 
better.’
E. Structure of transition
Transition clinic
‘A stand alone service for 16–25 year olds would be 
very useful.’
‘Consider adolescence extending to age 25 with 
transitional clinic’.
‘It is a good thought in setting up special service for 
transition process.’
Transition lead
‘Needs dedicated lead and feedback process. Thus 
one does have the opportunity for meetings between 
team members on specific cases.’
‘All Trusts should employ a dedicated whole time 
specialist nurse to oversee and support the transi-
tion process and ensure that clinicians are supported 
during process too.’
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Multidisciplinary team, and joint clinics, feedback 
between paediatric and adult services
‘I don’t transition patients to adults’ medical ser-
vice but I think it’s very important to have continu-
ity of the care and collaborations between medical 
professionals.’
‘Ideal for confidence: follow up by a mixed team 
child/adult.’
‘In many cases, a multidisciplinary psychological 
approach would be advisable.’
‘It’s very important to have system in place where 
pediatric and adult doctors collaborate with each other 
to maintain continuity of the medical care.’
‘The lack of collaboration between the special-
ties of pediatrics and immunoallergy interferes in a 
Fig. 1 Age of adolescents and young adults with allergy and asthma when healthcare professionals start the transition process and transfer 
to adult medical services. HCP, healthcare professionals; Paediatric HCP (n = 449) looking after 0–18 years old patients; adult HCP (n = 88) 
looking after ≥ 18 years old patients; all ages groups HCP (n = 642). 1179 participants contributed to the statistical analysis. * Depending on the 
developmental stage and readiness. ** Depending on their secondary school graduation; after school or after university; based on the needs, 
readiness, developmental status of AYA, provider choice/availability
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Fig. 2 Challenges for healthcare professionals across Europe when managing adolescents and young adults with allergy and asthma. Results for 
each based on data from 1179 respondents. Additional file 1: Figure S6 demonstrates that respondents from different clinic types are similarly likely 
to ask about each area
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negative way in the follow-up and orientation of 
adolescents.’
‘It is important that the teen feels safe, confident and 
emphathizes with the doctor who has seen him and 
with the one who will see him going forward, so that 
adherence to treatment and other measures are appro-
priate. This is achieved with a good flow between pae-
diatric pneumologist/allergists and adult allergists.’
F. Preconceptions about transition
Transition should happen even if AYA is not moving 
between medical services
‘The transition process is important for each patient. 
Even if they are not moving to adult care. Transition is 
a process of patient learning and self care.’
‘Sometimes clinicians think transition is the pro-
cess of moving between paediatric and adult services 
rather than discharging back to primary care. The 
importance of educating young adults about their 
conditions is underestimated however this is impera-
tive to help them manage their condition, minimise 
risk and prevent attacks/anaphylaxis.’
‘I think transition to adult services is less impor-
tant than a transition to adult management of their 
allergies. I.e. the transition is about reinforcing their 
independent management rather than about moving 
them to adult clinics.’
There was no need for transition if a HCP sees 
all ages of patient
‘If the same physician takes care of allergic patients 
from 0 to 100  years, there is no need for transition 
and the physician who knows better the disease state 
of the patient can decide whether it is recommend-
able to discharge or to continue the follow-up.’
‘In an allergy service where patients are seen 
throughout their whole life this problem is sorted.’
‘There is no transition. We see how the patient pro-
gresses as a whole from infancy.’
‘Allergists should be the specialists who see allergic 
patients regardless of their age and then there would 
be no problem with transition.’
‘The transition issue does not apply if patients of all 
ages are seen in a department in a suitable setting.’
‘Not applicable for my praxis, we treat and deal 
our paediatric patients continuously till adulthood.’
Seeing the same doctor is important
‘Is important to have same doctor because he 
knows more well your history.’
‘I believe that the best allergy care system is one 
where an allergist will patient all the time!’
AYA, adolescent and young adult; HCP, healthcare 
professionals. Healthcare professionals’ comments 
were summarised using a qualitative data analy-
sis approach. Text was divided into separate units, 
coded and summarized as themes in duplicate.
Fig. 2 continued
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Discussion
This is the first survey on AYA with allergies and asthma 
aiming to provide an insight into the current reality of 
transition practices of frontline HCPs across Europe. 
Although most respondents felt that transition care was 
important, only a minority had a transition process or 
policy in place, as per the National Institute for Health 
and Care Excellence guideline (NICE) in the UK [20] or 
the Children and Young’s People Allergy Network Scot-
land (CYANS) Transition Pathway in Scotland [21]. 
Moreover, transition care varies significantly by country 
and clinic type but it usually started late in adolescence. 
A small proportion of respondents had dedicated or spe-
cific resources for delivering transition care. Most did 
not see AYA alone for part of the consultation. There was 
often minimal liaison between paediatric and adult pri-
mary care and/or specialist services. The lack of specific 
training around AYA and the lack of transition guidelines 
for this group may be driving these significant limitations 
and variations in care.
According to the results of the survey, many allergy 
services do not have a transition process to support ado-
lescents to become independent patients. Comments 
from respondents suggest that many HCPs do not believe 
that transition is required when a clinic or service sees all 
age groups. However, all patients go through the similar 
developmental stages and require support and education 
in self-management of the disease despite staying within 
the same department. Where transition processes exist, 
they mostly start at 16–18 years and patients are trans-
ferred by age 18. It has been argued that preparations 
for transition should be initiated early, [8, 18, 19] around 
11–13  years, to allow the development of self-manage-
ment skills and optimise other health and well-being 
outcomes. Facilitation of independence in the children’s 
department is a vital step that prepares AYA to take 
responsibility for their lives and health prior to transition 
to adult services. Successful transition practices depend 
on the AYA’s developmental stage; thus HCPs should 
enable AYA to gradually take a leading role [8, 18]. 
Unfortunately, this survey shows that only 25% of HCPs 
have any consultation with the AYA without parents and 
only some addressed medical communication directly to 
AYA.
In many European countries the timing of transition of 
AYA from paediatric to adult care is determined by the 
patient’s chronological age (usually 18 years) rather than 
based on individual and patient-centred AYA readiness. 
Only 4.2% of HCPs reported that they use a question-
naire assessment to determine readiness for transition. 
Therefore, there is a need to help guide HCPs to initi-
ate transition when AYA are developmentally ready and 
nurture self-management skills. There are several generic 
instruments such as the ‘Transition Readiness Assess-
ment Questionnaire’ [22] (TRAQ), or ‘Ready Steady Go’ 
[23] that could be used to regularly access transition 
readiness. For instance, TRAQ has been shown to be a 
useful tool in measuring skills needed for successful tran-
sition in AYA with special health care needs and guiding 
educational interventions to support transition in dif-
ferent areas of life such as education, work and daily life 
[22].
Communication with AYA is key for smooth and suc-
cessful transition [15]. This should include holistic dis-
cussions about the disease, promotion of independence 
and self-management skills as well as other important 
areas of AYAs’ health and well-being. The HEADSS 
(Home, Education/Employment, peer group, Activi-
ties, Drugs, Sexuality, Suicide/depression) assessment 
has been successfully implemented in clinical practise 
to facilitate effective communication with AYA [24]. The 
results of this survey revealed that discussions about 
self-harm, sexuality, depression and drug use are mostly 
lacking in the majority of consultations with AYA with 
allergic diseases. HCPs have little confidence in asking 
and giving relevant advice about these areas despite self-
harm and depression being important co-morbidities in 
allergies and asthma [11].
To deliver a successful transition process, a multi-
disciplinary approach and feedback between paediatric 
and adult medical services are required [15]. This sur-
vey revealed that only a few clinics have social workers 
or psychologists available to help address transition-rel-
evant issues. Given that allergic diseases interact with 
psychological factors and are associated with increased 
anxiety, depression and suicidal thoughts [25–27] there 
is a need for an investment in training for HCPs in rec-
ognising mental health problems and direct access to 
specialists to address these needs. Poor communication 
between paediatric and adult clinicians was also identi-
fied by this survey. For instance, only 13% stated that 
they routinely sent a transition report, similar to those 
reported by adult endocrinologists, who identified it as 
a key barrier for successful transition. [28] In this survey 
even fewer (8.8% HCPs) reported they had a joint tran-
sition clinic with the AYA, his or her family, paediatric 
and adult HCPs; although a joint clinic is recommended 
in many disease-specific transition guidelines [29]. Pre-
venting patients becoming lost between paediatric and 
adult services has been identified as a major challenge 
for HCPs [30]. A transition lead who can coordinate and 
facilitate communication could be helpful [8, 18, 20] but 
is currently lacking (95.9% stated they did not have one).
Overall, differences in transition practices could be 
explained by the lack of training, dedicated resources 
and a guideline in the care of AYA with allergies and 
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asthma. A study of AYA with diabetes showed that a 
transition programme that consisted of disease educa-
tion, case management, transition clinic, transition web-
site and group classes improved adherence to follow up 
and health outcomes in comparison with usual care [31]. 
Several key components of the training in generic com-
ponents of transition have already been proposed in 
rheumatic diseases transition guidelines [18] and could 
be adjusted for HCPs working in the allergy field. There 
was a strongly positive reply from the survey respondents 
on the importance of transition for AYA with allergies 
and asthma which highlights the need to develop transi-
tion programmes for these patients.
Strengths and limitations of the survey
The survey was developed to be European representative; 
although there were several limitations. Firstly, it was lim-
ited to HCPs with membership of either EAACI or NAS, 
which could have caused selection bias. Secondly, it was 
not possible to obtain the number of members from each 
NAS to calculate the overlap with EAACI membership 
and therefore the precise response rate. Thirdly, those 
who did not participate might have different transition 
practices than the respondents of the survey. However, 
the results highlight the discrepancy and unmet need in 
transition care for AYA with allergies and asthma across 
Europe. The representativeness of the survey is likely to 
be high given the large number of HCPs who responded 
across Europe with good representation across countries, 
specialities, work settings and levels of experience. How-
ever, some countries were overrepresented which could 
potentially shift the overall results toward current prac-
tices in Italy, Russia, Spain and the United Kingdom. In 
addition, the response from some countries was too low 
to draw any national conclusion.
Implications
These survey results have important implications. The 
survey highlights deficits in current transition practice 
for AYA with allergy and asthma and the lack of specific 
training for HCPs in the care of this age group. Specific 
asthma and allergy ‘readiness to transition’ tools are not 
being used despite being able to ensure transition sup-
port is available at the developmentally appropriate time 
for individual patients. Further steps must focus on the 
development of evidence-based recommendations and 
standardization of the transition of care relevant to 
the needs of these patients. This should be agreed on a 
European level, acknowledging possible national differ-
ences in health care systems. It is hoped that a structured 
transition program will lead to improvements in patient 
knowledge, compliance, self-efficacy and self-manage-
ment. Furthermore, training in the generic transition 
process should be implemented in undergraduate and 
postgraduate training programmes. Lastly, these findings 
should focus policy makers on the need to invest in plan-
ning these transition services and appropriately resourc-
ing them.
Conclusions
This survey demonstrates significant limitations and vari-
ations in the delivery of transition practices for AYA with 
allergies and asthma in Europe. These findings should 
be used as a catalyst for standardisation and harmonisa-
tion of the delivery of transitional care across European 
countries to facilitate successful transition, improve well-
being and healthcare outcomes of these patients.
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